Targeted UHPLC‐QQQ‐MS‐based metabolomics analysis indicated that much lower concentrations of AhR ligands such as indole derivatives (IAA and IPA) were observed in fecal samples from animal models with metabolic diseases than those of their corresponding controls (Figure 2E). Here, AHR is linked to metabolic disease.